AS
Altshuler Shaham Portfolio holdings
AUM
$3.14B
1-Year Return
24.55%
This Quarter Return
+13.45%
1 Year Return
+24.55%
3 Year Return
+51.84%
5 Year Return
+71.45%
10 Year Return
–
AUM
$4.25B
AUM Growth
+$933M
(+28%)
Cap. Flow
+$574M
Cap. Flow
% of AUM
13.5%
Top 10 Holdings %
Top 10 Hldgs %
66.21%
Holding
431
New
106
Increased
115
Reduced
111
Closed
54
Top Buys
| 1 |
Consumers Staples Select Sector SPDR Fund
XLP
|
$467M |
| 2 |
Walmart
WMT
|
$226M |
| 3 |
Check Point Software Technologies
CHKP
|
$174M |
| 4 |
ICL Group
ICL
|
$126M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$91.9M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$430M |
| 2 |
Financial Select Sector SPDR Fund
XLF
|
$430M |
| 3 |
Mastercard
MA
|
$16.1M |
| 4 |
Tower Semiconductor
TSEM
|
$5.69M |
| 5 |
Ormat Technologies
ORA
|
$5.5M |
Sector Composition
| 1 | Technology | 30.13% |
| 2 | Financials | 19.76% |
| 3 | Consumer Discretionary | 17.08% |
| 4 | Consumer Staples | 5.55% |
| 5 | Healthcare | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Park Hotels & Resorts
PK
$2.4B
| $438K | 0.01% |
43,845
| – | – |
|
127
LivePerson
LPSN
$89.9M
| $435K | 0.01% |
8,284
-13,825
| -63% | -$726K |
|
128
Marriott International Class A Common Stock
MAR
$71.9B
| $419K | 0.01% |
4,522
-336
| -7% | -$31.1K |
|
129
Herbalife
HLF
$1.02B
| $373K | 0.01% |
8,000
-4,000
| -33% | -$187K |
|
130
Novartis
NVS
$251B
| $357K | 0.01% |
4,109
| – | – |
|
131
Pinterest
PINS
$25.8B
| $322K | 0.01% |
7,774
+874
| +13% | +$36.2K |
|
132
SPDR S&P Biotech ETF
XBI
$5.39B
| $254K | 0.01% |
+2,280
| New | +$254K |
|
133
GSK
GSK
$81.5B
| $221K | 0.01% |
4,688
| – | – |
|
134
DexCom
DXCM
$31.6B
| $219K | 0.01% |
2,120
+136
| +7% | +$14K |
|
135
Las Vegas Sands
LVS
$36.9B
| $205K | ﹤0.01% |
4,389
| – | – |
|
136
nVent Electric
NVT
$14.9B
| $202K | ﹤0.01% |
11,439
| – | – |
|
|
TVRD
137
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $185K | ﹤0.01% |
404
| – | – |
|
138
Revvity
RVTY
$10.1B
| $164K | ﹤0.01% |
1,303
-189
| -13% | -$23.8K |
|
139
Danaher
DHR
$143B
| $163K | ﹤0.01% |
855
-173
| -17% | -$33K |
|
140
Costco
COST
$427B
| $147K | ﹤0.01% |
415
-94
| -18% | -$33.3K |
|
|
CERN
141
DELISTED
Cerner Corp
CERN
| $143K | ﹤0.01% |
1,970
-928
| -32% | -$67.4K |
|
142
AbbVie
ABBV
$375B
| $142K | ﹤0.01% |
1,621
+1,018
| +169% | +$89.2K |
|
143
Johnson & Johnson
JNJ
$430B
| $142K | ﹤0.01% |
955
-3,107
| -76% | -$462K |
|
144
General Mills
GIS
$27B
| $141K | ﹤0.01% |
2,283
-314
| -12% | -$19.4K |
|
145
Bristol-Myers Squibb
BMY
$96B
| $138K | ﹤0.01% |
2,287
-617
| -21% | -$37.2K |
|
146
Insmed
INSM
$30.7B
| $137K | ﹤0.01% |
4,276
| – | – |
|
147
Garmin
GRMN
$45.7B
| $133K | ﹤0.01% |
1,399
+1,094
| +359% | +$104K |
|
148
ResMed
RMD
$40.6B
| $132K | ﹤0.01% |
773
+29
| +4% | +$4.95K |
|
149
Hormel Foods
HRL
$14.1B
| $131K | ﹤0.01% |
2,685
-604
| -18% | -$29.5K |
|
150
NVIDIA
NVDA
$4.07T
| $131K | ﹤0.01% |
9,640
-1,840
| -16% | -$25K |
|